Replies to post #742095 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

It would not be a novice mistake but a mistake born of hard experience with prior rallies which is why I am saying that if NWBO management cares about retail shareholders at all they should not leave us twisting in the wind as we did on May 10, 2022 when we were still waiting for the journal article to drop their big plan suggested was to protect TLD data from attack. Instead it came many months too late to help.

In short if they gave something else besides MHRA approval they need to say so up front and not waste precious hours or days as shareholders think history is repeating and they will once again he losers for holding in good faith while everyone else else the rally.

One could argue that shareholders should trust management and are to be blame if they sell ‘too early’ but after getting smacked upside he head with letdowns time after time in a pattern management at least contributed to by inaction, then management had at least some responsibility not to hide the ball from those who have invested for so long with so little to show for it. That’s reasonable and it is fair.

[skitahoe]

While I agree with you completely, in some companies I've seen a runup to approval followed by some retrenching, but eventually going substantially higher.

My point is that traders, those who buy, and sell for small gains, may trade successfully on such action. If the tax nightmare of constantly buying and selling is not a bother, enjoy such trading.

Personally I'm not thrilled by being out of a company because I made a small profit, but I know day traders who don't hold shares overnight. Not being in stock until the market opens avoids bad news before the open tanking a stock, but it also avoids big gains that may come from good news before the bell.

I like our odds at getting great news one of these days and I'm willing to hold for years after that happens as I believe it will just be the beginning of many great days.

Gary